Gene Therapy and Sickle Cell Disease

ASGCT
ASGCT
Published on 17.09.2020

Sickle cell disease is an inherited blood disorder that causes red blood cells to deform and become sickle (or crescent) shaped. Gene therapy and gene editing may offer a one-time treatment that addresses the genetic cause of sickle cell disease.

The subtitling of these videos was funded in part by a donation from Pfizer, Inc.

Runtime 00:04:30

sickle cell disease, SCD, gene therapy, ASGCT, American Society of Gene and Cell Therapy, ASH, ASH SCD, ASH Research Collaborative, ASH RC, SCD Clinical Trials Network, hematology, hematology society, ASH hematology,

COMMENTS: 0